1. Cognition and Quality of Life Among Survivors of Pediatric Non-CNS Cancers Receiving Ototoxic Therapy
- Author
-
Jacqueline R. Schechter, Susan S. Hayashi, Jennifer Henry, Anne Spence, Robert J. Hayashi, Kara Sauerburger, Molly Houdeshell, Judith E. C. Lieu, Taniya Varughese, and Allison A. King
- Subjects
Pediatrics ,medicine.medical_specialty ,Quality of life (healthcare) ,Occupational Therapy ,business.industry ,Childhood cancer ,Medicine ,Cancer ,Cognition ,business ,medicine.disease ,Chemotherapy regimen - Abstract
Date Presented 04/13/21 Children with cancer treated with platinum-based chemotherapy are at risk for developing hearing impairment (HI), one of several late effects associated with treatment. HI is associated with decreased socioemotional development, academic performance, and quality of life (QOL) among survivors of central nervous system (CNS) tumors. This is the first study to examine the impact of ototoxic HI on cognition and QOL among a cohort of survivors of pediatric non-CNS cancers. Primary Author and Speaker: Taniya Easow Varughese Contributing Authors: Julia Ferringer, Emily Grambo, Hannah Murkens, Jillian Smith, and Emily Scifo
- Published
- 2021
- Full Text
- View/download PDF